Showing results (1201-1210 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|April 26, 2013
Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in FinlandMiia Artama, Mika Gissler, Heli Malm, et al.Drug Safety|April 26, 2013
Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center DatabasePornwalai Boonmuang, Surakit Nathisuwan, Nathorn Chaiyakunapruk, et al.Drug Safety|March 1, 1990
Acute bone marrow aplasia associated with intravenous administration of deferoxamine (desferrioxamine)K Sofroniadou, M Drossou, L Foundoulaki, et al.Drug Safety|May 29, 2012
Aconite poisoning over 5 years: a case series in Hong Kong and lessons towards herbal safetySammy Pak Lam Chen, Sau Wah Ng, Wing Tat Poon, et al.Drug Safety|May 23, 2012
Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysisBehrooz K Shamloo, Pankdeep Chhabra, Andrew N Freedman, et al.Drug Safety|October 30, 2013
How well do various health outcome definitions identify appropriate cases in observational studies?Richard A Hansen, Michael D Gray, Brent I Fox, et al.Drug Safety|October 30, 2013
Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis systemG Niklas Norén, Tomas Bergvall, Patrick B Ryan, et al.Drug Safety|October 30, 2013
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databasesMartijn J Schuemie, Rosa Gini, Preciosa M Coloma, et al.Drug Safety|October 30, 2013
The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis systemChristian G Reich, Patrick B Ryan, Marc A SuchardPageof 311